Raphael J. Landovitz MD, MSc

Raphael J. Landovitz, MD, MSc, is a Professor of Medicine in the Division of Infectious Diseases at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is the Associate Director of the UCLA Center for Clinical AIDS Research & Education (CARE). He also serves as Co-Director of the UCLA Center for HIV Identification, Prevention, and Treatment Services (CHIPTS). Dr Landovitz received his BA in Chemistry from Princeton University in Princeton, New Jersey, and received his medical degree from Harvard Medical School in Boston, Massachusetts. He completed an internship, residency, and served as Chief Resident in Internal Medicine at Brigham and Women's Hospital in Boston, Massachusetts, and an Infectious Diseases fellowship with Brigham and Women's Hospital and Massachusetts General Hospital in Boston, Massachusetts. He served as Medical Co-Director of the Vietnam-CDC-Harvard Medical School-AIDS-Partnership (VCHAP), helping to train Vietnamese physicians in HIV care and treatment.

In 2006, Dr Landovitz joined the UCLA Center for Clinical AIDS Research and Education (CARE) where he is an infectious disease and HIV clinician and clinical investigator. His research interests include HIV prevention (including pre- and post-exposure prophylaxis and other combination prevention strategies) and the impact of such prevention interventions on risk behavior. Dr Landovitz works with the United States National Institutes of Health (NIH)-funded Division of AIDS (DAIDS) clinical trials networks for HIV therapeutics and HIV Prevention. He is has led numerous clinical trials, and currently leads the NIH trials developing long-acting injectable cabotegravir for HIV prevention. In 2010, he was awarded the John Carey Young Investigator Award by the AIDS Clinical Trials Group in 2010, and the American Association of HIV Medicine Research Award in 2017.